ATE240397T1 - Thiolprotease enthaltender impfstoff - Google Patents

Thiolprotease enthaltender impfstoff

Info

Publication number
ATE240397T1
ATE240397T1 AT93923592T AT93923592T ATE240397T1 AT E240397 T1 ATE240397 T1 AT E240397T1 AT 93923592 T AT93923592 T AT 93923592T AT 93923592 T AT93923592 T AT 93923592T AT E240397 T1 ATE240397 T1 AT E240397T1
Authority
AT
Austria
Prior art keywords
vaccine containing
containing thiol
thiol protease
protease
fluke
Prior art date
Application number
AT93923592T
Other languages
English (en)
Inventor
John Pius Dalton
Stuart Andrews
Original Assignee
John Pius Dalton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929222156A external-priority patent/GB9222156D0/en
Application filed by John Pius Dalton filed Critical John Pius Dalton
Application granted granted Critical
Publication of ATE240397T1 publication Critical patent/ATE240397T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641Cysteine endopeptidases (3.4.22)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
AT93923592T 1992-10-21 1993-10-21 Thiolprotease enthaltender impfstoff ATE240397T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929222156A GB9222156D0 (en) 1992-10-21 1992-10-21 Vaccine
GB939307028A GB9307028D0 (en) 1992-10-21 1993-04-02 Vaccine
PCT/GB1993/002172 WO1994009142A1 (en) 1992-10-21 1993-10-21 Vaccine containing a thiol protease

Publications (1)

Publication Number Publication Date
ATE240397T1 true ATE240397T1 (de) 2003-05-15

Family

ID=26301834

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93923592T ATE240397T1 (de) 1992-10-21 1993-10-21 Thiolprotease enthaltender impfstoff

Country Status (12)

Country Link
US (2) US6623735B1 (de)
EP (1) EP0666919B1 (de)
JP (1) JPH08502404A (de)
AT (1) ATE240397T1 (de)
AU (1) AU5340094A (de)
CA (1) CA2147378A1 (de)
DE (1) DE69332977T2 (de)
DK (1) DK0666919T3 (de)
ES (1) ES2199947T3 (de)
NZ (1) NZ257148A (de)
PT (1) PT666919E (de)
WO (1) WO1994009142A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795768A (en) * 1991-02-12 1998-08-18 Heska Corporation Filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof
US6419923B1 (en) 1991-02-12 2002-07-16 Heska Corporation Filariid nematode cysteine protease proteins, and uses thereof
EP0647138A4 (de) * 1993-02-05 1996-03-06 Daratech Pty Ltd Polypeptide erhältlich aus fasciola spezien, und vakzine, therapieverfahren und dna sequenzen diese peptide kodierend.
GB9312324D0 (en) * 1993-06-15 1993-07-28 Pitman Moore Inc Vaccine
AU702915B2 (en) * 1994-05-26 1999-03-11 Heska Corporation Novel parasite protease genes and proteins
GB9419969D0 (en) * 1994-10-04 1994-11-16 Mallinckrodt Veterinary Inc Vaccine
GB9612214D0 (en) 1996-06-11 1996-08-14 Mallinckrodt Veterinary Inc Vaccine
TR199902609T2 (xx) * 1997-03-11 2000-06-21 Stichting Dienst Landbouwkundig Onderzoek Parazitlere kar�� koruyucu ba����kl���n �l��lmesi i�in y�ntem olarak bir eks vivo hayvan ya da y�kleme modeli ve bahsedilen y�ntemde koruyucu oldu�u g�sterilmi� a��lar.
PL201419B1 (pl) * 2002-12-04 2009-04-30 Inst Biotechnologii I Antybiot Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina
WO2011043962A2 (en) 2009-10-07 2011-04-14 Wyeth Llc Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8432401D0 (en) * 1984-12-21 1985-02-06 Bennett C E Liver fluke antigens
NZ232327A (en) * 1989-01-31 1993-02-25 Daratech Pty Ltd Vaccine for preventative treatment of liver fluke infection in ruminants comprising as an antigen glutathione-s-transferase (gst) of f. hepatica
WO1993010225A1 (en) * 1991-11-12 1993-05-27 The Colorado State University Research Foundation Protease vaccine against heartworm
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof

Also Published As

Publication number Publication date
EP0666919A1 (de) 1995-08-16
EP0666919B1 (de) 2003-05-14
CA2147378A1 (en) 1994-04-28
WO1994009142A1 (en) 1994-04-28
US20050208063A1 (en) 2005-09-22
PT666919E (pt) 2003-09-30
DE69332977T2 (de) 2004-05-19
NZ257148A (en) 1996-04-26
DE69332977D1 (de) 2003-06-18
JPH08502404A (ja) 1996-03-19
DK0666919T3 (da) 2003-09-08
US6623735B1 (en) 2003-09-23
ES2199947T3 (es) 2004-03-01
AU5340094A (en) 1994-05-09

Similar Documents

Publication Publication Date Title
DK0656888T3 (da) Sulfonylalkanoylaminohydroxyethylaminosulfonamider, anvendelige som retrovirale protease-inhibitorer
DE68918952T2 (de) Emulsionen von perfluorhaltigen organischen verbindungen.
ATE148113T1 (de) Retrovirale protease inhibitoren, enthaltend cyclische sulfone
FI950841A0 (fi) Retrovirusproteaasi-inhibiittoreina käyttökelpoisia N-(alkanoyyliamino-2-hydroksipropyyli)-sulfoniamideja
ATE296625T1 (de) Retrovirusprotease inhibitoren
ES2150933T3 (es) Inhibidores de la proteasa vih utiles para el tratamiento del sida.
ATE196466T1 (de) Inhibitoren retroviraler proteasen
DE69332977D1 (de) Thiolprotease enthaltender impfstoff
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
DE69326077D1 (de) Sulfonylalkanoylaminohydroxyethylaminosulfaminsäuren verwendbar als inhibitoren retroviraler proteasen
HUP9802971A1 (hu) Az MMP-inhibitorok alkalmazása a szemben történő érképződés kezelésére
FI884955A (fi) Konserverade haor- och hudrengoeringsmedel och anvaendning av en konserveringsmedelkombination.
DE69737500D1 (de) Von willebrand-faktor multimerase
DK0703789T3 (da) Vaccine indeholdende en serinprotease
BE876296A (fr) Compositions pharmaceutiques contenant des prostaglandines
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
ATE158304T1 (de) Dithiolanylglycinhaltige hiv-proteaseinhibitoren vom hydroxyethylenisostertyp
NO950897L (no) Inhibisjon av retro virusinfeksjon
PT878195E (pt) Utilizacao de um composto 2-aroil-3-arilbenzo(b)tiofeno para a reducao de fibrinogenio
ES2067140T3 (es) Compuestos fenilester de acido benzoico y composiciones inhibidoras de la elastasa que contienen los mismos.
GR1001368B (el) Φαρμακευτικοί φορείς.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0666919

Country of ref document: EP

REN Ceased due to non-payment of the annual fee